During the past decade, Karolinska Universitetssjukhuset Solna, Centrum för Hematologi, Stockholm conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Karolinska Universitetssjukhuset Solna, Centrum för Hematologi, Stockholm" #1 collaborator was "Pharmacyclics LLC." with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Karolinska Universitetssjukhuset Solna, Centrum för Hematologi, Stockholm" are "Chronic Graft Versus Host Disease" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials), "Diffuse Large B-cell Lymphoma" (1 trials), "Follicular Lymphoma" (1 trials) and "Leukemia, Lymphocytic, Chronic, B-Cell" (1 trials). Many other conditions were trialed in "Karolinska Universitetssjukhuset Solna, Centrum för Hematologi, Stockholm" in a lesser frequency.

Most popular intervention types in "Karolinska Universitetssjukhuset Solna, Centrum för Hematologi, Stockholm" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Ibrutinib" (2 trials), "Chlorambucil" (1 trials), "Ibrutinib (as Subsequent Therapy)" (1 trials), "Obinutuzumab" (1 trials) and "Venetoclax" (1 trials). Other intervention names were less common.

The vast majority of trials in "Karolinska Universitetssjukhuset Solna, Centrum för Hematologi, Stockholm" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Karolinska Universitetssjukhuset Solna, Centrum för Hematologi, Stockholm". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were undefined completed trials in Karolinska Universitetssjukhuset Solna, Centrum för Hematologi, Stockholm, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Karolinska Universitetssjukhuset Solna, Centrum för Hematologi, Stockholm, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".